[go: up one dir, main page]

WO2008152490A3 - Loaded target-specific vesicles, method of producing the vesicles and their use in medical imaging - Google Patents

Loaded target-specific vesicles, method of producing the vesicles and their use in medical imaging Download PDF

Info

Publication number
WO2008152490A3
WO2008152490A3 PCT/IB2008/001523 IB2008001523W WO2008152490A3 WO 2008152490 A3 WO2008152490 A3 WO 2008152490A3 IB 2008001523 W IB2008001523 W IB 2008001523W WO 2008152490 A3 WO2008152490 A3 WO 2008152490A3
Authority
WO
WIPO (PCT)
Prior art keywords
vesicles
imaging
medical imaging
producing
targetable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2008/001523
Other languages
French (fr)
Other versions
WO2008152490A2 (en
Inventor
Pavel Broz
Sergey Driamov
Wolfgang Meier
Patrick Hunziker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitaet Basel
Universitaetsspital Basel USB
Original Assignee
Universitaet Basel
Universitaetsspital Basel USB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaet Basel, Universitaetsspital Basel USB filed Critical Universitaet Basel
Publication of WO2008152490A2 publication Critical patent/WO2008152490A2/en
Anticipated expiration legal-status Critical
Publication of WO2008152490A3 publication Critical patent/WO2008152490A3/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1887—Agglomerates, clusters, i.e. more than one (super)(para)magnetic microparticle or nanoparticle are aggregated or entrapped in the same maxtrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

This invention relates to targetable vesicles and targetable vesicle-based contrast agents imaging in clinical medicine including in vitro and in vivo imaging. Enzyme nanoreactors having polymer membranes are used to precipitate highly insoluble nanoparticles inside the vesicles. Surface modification with targeting moieties such as the macrophage scavenger receptor A1 (SRA-1) ligand polyguanylic acid and fluorescence-labeled streptavidin provides bimodal target-specific vesicles providing contrast for medical imaging such as MR and fluorescence imaging.
PCT/IB2008/001523 2007-06-14 2008-06-13 Loaded target-specific vesicles, method of producing the vesicles and their use in medical imaging Ceased WO2008152490A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94394907P 2007-06-14 2007-06-14
US60/943,949 2007-06-14

Publications (2)

Publication Number Publication Date
WO2008152490A2 WO2008152490A2 (en) 2008-12-18
WO2008152490A3 true WO2008152490A3 (en) 2010-06-24

Family

ID=39940627

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2008/001523 Ceased WO2008152490A2 (en) 2007-06-14 2008-06-13 Loaded target-specific vesicles, method of producing the vesicles and their use in medical imaging

Country Status (1)

Country Link
WO (1) WO2008152490A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009034458A2 (en) * 2007-09-11 2009-03-19 Universität Basel Oxygen permeable polymeric nanocontainers for encapsulation of sensitive compounds
US20140141089A1 (en) * 2009-02-11 2014-05-22 Colorado School Of Mines Nanoparticles, Compositions Thereof, and Methods of Use, and Methods of Making the Same
US20110201076A1 (en) 2010-01-22 2011-08-18 Colorado School Of Mines Harvesting micro algae
CN104013967B (en) * 2014-04-25 2016-06-15 同济大学 A kind of gadolinium polymer vesicle and its preparation method and application that carries
ES2797026T3 (en) * 2014-12-23 2020-12-01 Univ Basel Amphiphilic Polymer Systems
CN109125744B (en) * 2018-08-24 2021-04-23 浙江大学 A preparation method of gadolinium-doped hafnium oxide nanoparticles with MRI and CT dual-modal imaging functions
CN109364245B (en) * 2018-09-04 2021-06-25 中山大学 A kind of polydopamine nanodiagnostic agent and preparation method thereof
EP4087927A4 (en) 2020-01-09 2024-01-24 Ensovi, Inc. Artificial organelles for enzymatic cofactor reduction
CN116270456B (en) * 2023-04-27 2024-11-22 北京华靳制药有限公司 A kind of sodium fructose diphosphate oral solution and preparation method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001032146A2 (en) * 1999-11-05 2001-05-10 Biocure, Inc. Amphiphilic polymeric vesicles

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001032146A2 (en) * 1999-11-05 2001-05-10 Biocure, Inc. Amphiphilic polymeric vesicles

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BROZ P ET AL: "Cell targeting by a generic receptor-targeted polymer nanocontainer platform", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL LNKD- DOI:10.1016/J.JCONREL.2004.10.014, vol. 102, no. 2, 2 February 2005 (2005-02-02), pages 475 - 488, XP004710972, ISSN: 0168-3659 *
BROZ PAVEL ET AL: "Toward intelligent nanosize bioreactors: a pH-switchable, channel-equipped, functional polymer nanocontainer. Supporting information", NANOLETTERS, vol. 6, no. 10, October 2006 (2006-10-01), DOI: http://pubs.acs.org/doi/suppl/10.1021/nl0619305/suppl_file/nl061 *
BROZ PAVEL ET AL: "Toward intelligent nanosize bioreactors: a pH-switchable, channel-equipped, functional polymer nanocontainer.", NANO LETTERS OCT 2006 LNKD- PUBMED:17034109, vol. 6, no. 10, October 2006 (2006-10-01), pages 2349 - 2353, XP002577205, ISSN: 1530-6984 *
INVITROGEN CORPORATION: "ELFŸ 97 Endogenous Phosphatase Detection Kit (Cat. n° E6601)", XP002577206, Retrieved from the Internet <URL:HTTP://WWW.INVITROGEN.COM/SITE/US/EN/HOME/SUPPORT/PRODUCT-TECHNICAL-RESOURCES/PRODUCT-STRUCTURES.-06601.HTML> [retrieved on 201004] *
SAUER M ET AL: "Ion-carrier controlled precipitation of calcium phosphate in giant ABA triblock copolymer vesicles", CHEMICAL COMMUNICATIONS 20011207 GB, no. 23, 7 December 2001 (2001-12-07), pages 2452 - 2453, XP002577207, ISSN: 1359-7345 *

Also Published As

Publication number Publication date
WO2008152490A2 (en) 2008-12-18

Similar Documents

Publication Publication Date Title
WO2008152490A3 (en) Loaded target-specific vesicles, method of producing the vesicles and their use in medical imaging
Unnikrishnan et al. Fluorescent carbon dots for selective labeling of subcellular organelles
Mousavi et al. Applications of graphene oxide in case of nanomedicines and nanocarriers for biomolecules: review study
Feng et al. Versatile catalytic deoxyribozyme vehicles for multimodal imaging-guided efficient gene regulation and photothermal therapy
Feng et al. The acidic tumor microenvironment: a target for smart cancer nano-theranostics
Jia et al. Preparation of dual-template epitope imprinted polymers for targeted fluorescence imaging and targeted drug delivery to pancreatic cancer BxPC-3 cells
Toh et al. Nanodiamond–mitoxantrone complexes enhance drug retention in chemoresistant breast cancer cells
Jin et al. Polymer-coated NaYF4: Yb3+, Er3+ upconversion nanoparticles for charge-dependent cellular imaging
Costagliola di Polidoro et al. Theranostic design of angiopep-2 conjugated hyaluronic acid nanoparticles (Thera-ANG-cHANPs) for dual targeting and boosted imaging of glioma cells
Lin et al. Critical considerations in the biomedical use of mesoporous silica nanoparticles
Zhang et al. Self‐assembled organic/metal ion nanohybrids for theranostics
WO2010083337A3 (en) Composite nanostructures and methods for making and using them
Throat et al. Macromolecular Poly (N‐isopropylacrylamide)(PNIPAM) in Cancer Treatment and Beyond: Applications in Drug Delivery, Photothermal Therapy, Gene Delivery and Biomedical Imaging
WO2009073193A3 (en) Methods of synthesis and use of chemospheres
WO2009112488A3 (en) Polyether polyol dendron conjugates with effector molecules for biological targeting
WO2005089106A3 (en) Degradable nanoparticles
WO2008100817A3 (en) Polycyclo dyes and use thereof
Chen et al. Responsive prodrug self-assembled vesicles for targeted chemotherapy in combination with intracellular imaging
WO2014093696A3 (en) Insulin derivatives for diabetes treatment
WO2010131907A3 (en) Sirna delivery system using self-assembled polymeric nanoparticles
Maurici et al. Hyperthermia enhances efficacy of chemotherapeutic agents in pancreatic cancer cell lines
WO2009103741A3 (en) Use of fsh receptor ligands for diagnosis and therapy of cancer
EP3441467A3 (en) Biotin complexes for treatment and diagnosis of alzheimer&#39;s disease
WO2008141111A3 (en) Polymers conjugated with platinum drugs
Das et al. Enzyme-responsive biopolymeric nanogel fibers by extrusion: engineering of high-surface-area hydrogels and application in bacterial enzyme detection

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08762856

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08762856

Country of ref document: EP

Kind code of ref document: A2